Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Lorlatinib: the crown jewel of ALK inhibitors.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: June 15, 2026
Neoadjuvant therapy for patients with nonsmall cell lung cancer: Not as easy in the real world.
Journal: Cancer
Published: February 17, 2026
Evaluating the safety and efficacy of chemotherapy in patients with relapsed small cell lung cancer combined with allopurinol and MycoPhenolate (CLAMP).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: February 12, 2026
Lead-in therapy targeting PD1 and/or LAG3 imposes distinct immune phenotypes in first-line treatment of metastatic melanoma.
Journal: medRxiv : the preprint server for health sciences
Published: November 24, 2025
Dysfunctional CD11c-CD21- extrafollicular memory B cells are enriched in the periphery and tumors of patients with cancer.
Journal: Science translational medicine
Published: February 19, 2025
A Pulmonary Nodule with an Unexpected Mutation Profile.
Journal: Clinical chemistry
Published: June 07, 2024
Blockade of LAG-3 and PD-1 leads to co-expression of cytotoxic and exhaustion gene modules in CD8+ T cells to promote antitumor immunity.
Journal: Cell
Published: February 09, 2023
Targeting KRAS G12C mutation in lung adenocarcinoma.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 30, 2021
Beyond PD-1: The Next Frontier for Immunotherapy in Melanoma.
Journal: Frontiers in oncology
Published: December 11, 2020
Cancer vaccine induces potent T cell responses - but is it enough?
Journal: Nature reviews. Clinical oncology
Published: September 26, 2020
Last Updated: 09/26/2026